The 3B Lab is happy to share that we will be participating in the NSF I-Corps program to help explore the commercial potential of our antifungal peptides. The work will be headed by Entrepreneurial Lead and 3B Lab member Dr. Robert J Tancer. Our goal will be to determine the viability of synergistic drug combinations to combat antifungal resistance. We would love to chat with people from around the country and world on this topic, please feel free to reach out!
https://beta.nsf.gov/funding/initiatives/i-corps
